Major depression drug recalled over wrong dosage.
The first FDA-approved to reduce functional abdominal pain in younger patients with irritable bowel syndrome is now available to medical providers.
A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.
The first respiratory biologic to be approved for administration via an autoinjector will be available in the US soon.
Walgreens is partnering with VillageMD to create primary care clinics in Texas
Major blockbuster drugs slated for launch in 2019 are expected to have a significant impact on treating certain cancers, diabetes, peanut allergies, and other conditions.
There is finally relief from “gag clauses,” which prevented pharmacists from telling patients they can pay a lower out-of-pocket cost for certain prescriptions than the copay with their health insurance.
In the past week, the migraine prevention drug market has suddenly heated up, with 2 new approvals by FDA.
A new study reveals interesting findings about improving the health of pediatric asthma patients and integrated care programs.
While breastfeeding has been thought to decrease children’s risk of developing allergies and asthma, a new study counters that belief.